<p>A Clinical Review and Critical Evaluation of Imipenem-Relebactam: Evidence to Date</p>-Reference-Cited by-同舟云学术

A Clinical Review and Critical Evaluation of Imipenem-Relebactam: Evidence to Date

Published:2020-11 Issue: Volume:Volume 13 Page:4297-4308
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Campanella Toni A^ORCID,Gallagher Jason C^ORCID

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference64 articles.

1. Centers for Disease Control and Prevention (U.S.). Antibiotic Resistance Threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.); 2019.

2. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis

3. Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis

4. Comparative Review of the Carbapenems

5. In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining Aloin with TIENAM ameliorates cecal ligation and puncture-induced sepsis in mice by attenuating inflammation and modulating abdominal cavity microbiota;International Immunopharmacology;2024-11

2. Isolation and Antimicrobial Susceptibility of Some Bacteria From The Gut of Honey Bees in Siirt Province of Türkiye;Animal Health Production and Hygiene;2024-06-28

3. Hidden threats in the plastisphere: Carbapenemase-producing Enterobacterales colonizing microplastics in river water;Science of The Total Environment;2024-04

4. Worldwide trend discovery of structural and functional relationship of metallo-β-lactamase for structure-based drug design: A bibliometric evaluation and patent analysis;International Journal of Biological Macromolecules;2024-01

5. Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa;European Journal of Clinical Microbiology & Infectious Diseases;2023-12-29